FDA Approves First New Type of Herpes Antiviral in Nearly 30 Years
For patients with weakened immune systems, a herpes simplex virus (HSV) infection can become much more than an uncomfortable outbreak. Some…
A $5.8 Billion Deal Is Betting That More Complex Drug Therapy Will Move Closer to Home. Pharmacists Should Pay Attention.
This week, one of the biggest deals in healthcare dropped. And it has everything to do with where pharmacy is headed. On October 6, McKesson…
GLP-1 Was Just the Beginning. The First Triple-Hormone Obesity Drug Now Has Phase 3 Data
For the last several years, one acronym has dominated the conversation around obesity treatment: GLP-1. First came drugs that targeted the…
Drug Development Takes More Than a Decade. A New Federal Program Wants to Cut Clinical Trials to Under Four Years.
Most pharmacists learn clinical development as a sequence of distinct steps. A drug enters Phase 1, moves into Phase 2 if the early evidence…
Insulin Just Went From 365 Injections a Year to 52. Now Two Once-Weekly Options Are Approved.
For more than a century, insulin has steadily evolved. We’ve developed faster insulins for meals, longer-acting insulins for basal…